Avik Chatterjee MD, MPH

Assistant Professor, General Internal Medicine

801 Massachusetts Ave | (617) 414-7399
Avik Chatterjee
Sections

General Internal Medicine

Centers

Clinical Addiction Research and Education Unit

Evans Center for Interdisciplinary Biomedical Research

Biography

Dr. Chatterjee is a med-peds trained primary care and addiction medicine physician at several shelter-based clinics through Boston Health Care for the Homeless Program. His areas of clinical and research interest include innovative treatment models for opioid use disorder in marginalized populations, and interventions on social determinants of health, such as food insecurity. He has an additional interest in racism and health care, particularly its manifestations in medical education and training.

Education

Medicine, MD, University of North Carolina at Chapel Hill

Publications

Published on 8/18/2025

Zaragoza S, Silcox J, Rapisarda S, Summers C, Case P, To C, Chatterjee A, Walley AY, Komaromy M, Green TC. Correction: Developing a comprehensive inventory to define harm reduction housing. Harm Reduct J. 2025 Aug 18; 22(1):142. PMID: 40826084.

Published on 8/1/2025

Johnson L, Chatterjee A. The expiration of the Addiction Medicine Practice-based Pathways will increase the specialty's challenges. J Stud Alcohol Drugs. 2025 Aug 01. PMID: 40748286.

Published on 7/31/2025

Harris MTH, Hall M, Ellison S, Holloway J, Bridden C, Bagley SM, Bullard M, Chassler D, Chatterjee A, Dasgupta A, Drainoni ML, Gruss DE, Jadovich E, Katz R, Mayotte C, Neufeld JL, Oga E, Glasgow L. Tailored strategies to reduce opioid overdose deaths for pregnant and postpartum women: Examples and lessons learned from the HEALing Communities Study. J Subst Use Addict Treat. 2025 Oct; 177:209766. PMID: 40752834.

Published on 7/7/2025

Levengood TW, Shaw LC, Zang X, Schackman BR, Walley AY, Urquhart C, Green TC, Chatterjee A, Marshall BDL, Morgan JR. A geospatial analysis of naloxone distribution patterns in the Massachusetts overdose education and naloxone distribution program (MA OEND). Drug Alcohol Depend. 2025 Sep 01; 274:112783. PMID: 40683013.

Published on 6/2/2025

Zwick H, O'Dea R, Barocas JA, Flam-Ross JM, Chatterjee A, Walley AY, Harris RA, Schackman BR, White LF, Chrysanthopoulou SA, Assoumou SA, Murphy SM, Morgan JR, Baptiste D, Carroll M, Linas BP. Health and Economic Outcomes of Addressing Encampments of Individuals Using Opioids. JAMA Netw Open. 2025 Jun 02; 8(6):e2517095. PMID: 40577017.

Published on 5/25/2025

Gibson EB, Glasgow L, Nouvong M, McGladrey M, Freedman D, Chassler D, Vickers-Smith R, D'Onfro M, Goddard-Eckrich DA, Hunt T, Chatterjee A, Holloway J, Fain K, Cruz RS, Martinez LS. Implementing and documenting cultural adaption of evidence-based practice strategies to reduce opioid overdose deaths: examples and lessons from the HEALing communities study. Discov Public Health. 2025; 22(1):296. PMID: 40433450.

Published on 5/9/2025

Renehan CM, Wiggins M, Puppala R, Chatterjee A, Obando A, Coleman KR, Raj A, Schmill DM, Flynn D, Bagley SM. A Scoping Review of Youth Overdose Prevention Interventions. J Addict Med. 2025 May 09. PMID: 40344021.

Published on 4/19/2025

Noyes E, Hausman E, Yeo EJ, Bain PA, Bannister M, Lopez IB, Rajakumar B, Wang G, Chatterjee A. Harm reduction interventions for AYA who use opioids: A scoping review. Drug Alcohol Depend. 2025 Jul 01; 272:112677. PMID: 40339383.

Published on 1/23/2025

Zaragoza S, Silcox J, Rapisarda S, Summers C, Case P, To C, Chatterjee A, Walley AY, Komaromy M, Green TC. Developing a comprehensive inventory to define harm reduction housing. Harm Reduct J. 2025 Jan 23; 22(1):11. PMID: 39849487.

Published on 11/29/2024

Johnson NL, Beaugard CA, Heredia-Perez D, So-Armah K, Reason P, Yule AM, Lee CS, Chapman SE, Chatterjee A, McClay C, Weeden T, Becerril C, Thomas D, Komaromy M. Embracing anti-racism: Co-creating recommendations with Black people for how addiction treatment needs to change. Soc Sci Med. 2025 Jan; 364:117433. PMID: 39615095.

View full list of 71 publications.